Analyst Ratings For Taro Pharmaceutical Industries (NYSE:TARO)
Today, HC Wainwright initiated coverage on Taro Pharmaceutical Industries (NYSE:TARO) with a Buy with a price target of $124.00.
Some recent analyst ratings include
- 3/12/2018-HC Wainwright initiated coverage with a Buy rating.
- 5/23/2017-Credit Suisse Group was Downgraded by analysts at Credit Suisse Group from a “Outperform ” rating to a ” Neutral” rating.
Recent Trading Activity for Taro Pharmaceutical Industries (NYSE:TARO)
Shares of Taro Pharmaceutical Industries closed the previous trading session at 101.31 up +1.13 1.13% with 1972 shares trading hands.